| Literature DB >> 25889565 |
Abstract
BACKGROUND: This study aimed to determine the awareness among fifth-grade girls and boys of sexually transmitted diseases (STDs), cancer, and human papillomavirus (HPV), and to determine the factors associated with intention to obtain the HPV vaccination.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25889565 PMCID: PMC4339239 DOI: 10.1186/s12914-015-0042-2
Source DB: PubMed Journal: BMC Int Health Hum Rights ISSN: 1472-698X
Gender comparisons of the general characteristics at pretest
|
|
|
|
|
|
|---|---|---|---|---|
|
| ||||
| Age (years) | 11.97±0.17 | 12.00±0.00 | 1.36 (0.246) | |
| 11 | 1 (2.9) | 0 (0.0) | ||
| 12 | 68 (97.1) | 47 (100.0) | ||
| Feelings about vaccine injection ( | Afraid | 6 (8.7) | 13 (28.3) | 7.66 (0.006) |
| Not afraid | 63 (91.3) | 33 (71.1) | ||
| Need for vaccination | Know | 60 (85.7) | 39 (83.0) | 0.16 (0.688) |
| Don’t know | 10 (14.3) | 8 (17.0) | ||
| Heard of viruses ( | Yes | 7 (10.3) | 13 (28.3) | 6.12 (0.013) |
| No | 61 (89.7) | 33 (71.7) | ||
| Known virusesa | Flu/influenza | 15 (14.6) | 10 (20.0) | |
| H1N1 | 51 (49.5) | 16 (32.0) | ||
| Avian flu | 1 (1.0) | - | ||
| Encephalitis | 4 (3.9) | 1 (2.0) | ||
| Hepatitis | 5 (4.9) | - | ||
| Tetanus | 2 (1.9) | - | ||
| Smallpox | 2 (1.9) | - | ||
| Varicella | 1 (1.0) | 2 (4.0) | ||
| Ebola | 1 (1.0) | - | ||
| HPV | 2 (1.9) | - | ||
| STD | - | 1 (2.0) | ||
| Pneumonia | - | 2 (4.0) | ||
| Rabies | - | 1 (2.0) | ||
| Don’t know or misunderstand | 18 (17.5) | 17 (34.0) | ||
aMultiple responses possible.
STD, sexually transmitted disease; HPV, human papillomavirus.
Gender comparisons of awareness of STDs and cancer prevention between pre- and posttest
|
|
|
|
|
| |||
|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||
| Viral infection is preventable | Yes | 49 (70.0) | 30 (63.8) | 1.14 (0.566) | 63 (90.0) | 45 (97.8) | 2.65 (0.104) |
| No | 1 (1.4) | 2 (4.3) | 0 (0) | 0 (0) | |||
| Don’t know | 20 (28.6) | 15 (31.9) | 7 (10.0) | 1 (2.2) | |||
| STDs are preventable | Yes | 25 (35.7) | 6 (12.8) | 8.76 (0.013) | 64 (91.4) | 42 (93.3) | 2.24 (0.327) |
| No | 0 (0) | 1 (2.1) | 0 (0) | 1 (2.2) | |||
| Don’t know | 45964.3) | 40 (85.1) | 6 (8.6) | 2 (4.4) | |||
| Cancer is preventable | Yes | 43 (61.4) | 18 (38.3) | 6.37 (0.041) | 60 (85.7) | 41 (89.1) | 2.03 (0.369) |
| No | 4 (5.7) | 6 (12.8) | 1 (1.4) | 2 (4.3) | |||
| Don’t know | 23 (32.9) | 23 (48.9) | 9 (12.9) | 3 (6.5) | |||
| Time to begin STD prevention | Onset of puberty | 33 (61.1) | 29 (72.5) | 1.67 (0.434) | 67 (95.7) | 45 (97.8) | 0.37 (0.542) |
| Adulthood | 11 (20.4) | 7 (17.5) | 3 (4.3) | 1 (2.2) | |||
| Not necessary | 10 (18.5) | 4 (10.0) | 0 (0) | 0 (0) | |||
| Time to begin cancer prevention | Onset of puberty | 28 (45.2) | 23 (50.0) | 0.78 (0.677) | 49 (70.0) | 36 (78.3) | 0.97 (0.325) |
| Adulthood | 27 (43.5) | 20 (43.5) | 21 (30.0) | 10 (21.7) | |||
| Not necessary | 7 (11.3) | 3 (6.5) | 0 (0.0) | 0 (0.0) | |||
| Methods of STD preventiona | Abstinence | 0 (0.0) | 1 (2.1) | - | 9 (7.9) | 8 (10.7) | - |
| Condom use | 2 (2.9) | 0 (0.0) | 39 (34.2) | 22 (29.3) | |||
| Genital examination | 1 (1.4) | 1 (2.1) | 22 (19.3) | 16 (21.3) | |||
| Hygiene habits | 7 (10.0) | 6 (12.8) | 30 (26.3) | 16 (21.3) | |||
| None | 3 (4.3) | 1 (2.1) | 3 (2.6) | 1 (1.3) | |||
| Don’t know | 53 (75.7) | 37 (78.7) | 11 (9.6) | 12 (16.0) | |||
aMultiple response.
Pre, pretest; post, posttest.
STD, sexually transmitted disease.
Gender comparisons of health-belief variables related to STDs and cancer prevention between pre- and posttest
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
|
| |||||||
|
|
|
|
| |||||
| Severity of STD | 2.94±0.85 | 3.07±0.65 | −1.14 (0.255) | 3.81±0.97 | 3.64±0.71 | −1.08 (0.281) | −5.53 (<0.001) | −3.67 (<0.001) |
| Severity of cancer | 3.99±1.20 | 4.04±0.95 | −0.25 (0.806) | 4.30±0.86 | 4.28±0.58 | −0.79 (0.432) | −2.38 (0.017) | −1.82 (0.069) |
| Intention to obtain injection for STD prevention | 3.52±0.85 | 3.28±0.93 | −1.14 (0.253) | 4.11±0.81 | 4.26±0.57 | −0.76 (0.445) | −5.08 (<0.001) | −4.85 (<0.001) |
| Intention to obtain injection for cancer prevention | 4.23±0.79 | 4.09±0.80 | −1.08 (0.282) | 4.30±0.69 | 4.37±0.57 | −0.35 (0.723) | −1.24 (0.216) | −2.81 (0.005) |
| Concern about pain at vaccine injectiona | 3.09±1.04 | 2.62±1.05 | −2.44 (0.015) | 3.29±1.13 | 2.76±1.10 | −2.31 (0.021) | −2.21 (0.026) | −1.11 (0.268) |
| Benefit of STD prevention injection | 3.59±0.87 | 3.54±0.75 | −0.10 (0.921) | 4.19±0.73 | 4.07±0.58 | −1.09 (0.278) | −4.68 (<0.001) | −3.76 (<0.001) |
| Benefit of cancer prevention injection | 4.03±0.93 | 3.98±0.74 | −0.58 (0.564) | 4.32±0.74 | 4.31±0.51 | −0.57 (0.570) | −3.52 (<0.001) | −2.80 (0.005) |
| Cronbach’s α for seven items=0.78 | ||||||||
aReverse coding.
*Mann–Whitney U test, ϯWilcoxon signed-rank test.
STD, sexually transmitted disease.
Gender comparisons of intention to obtain HPV vaccination and HPV knowledge at posttest
|
|
|
| |
|---|---|---|---|
|
| |||
| Intention to obtain HPV vaccination (score 1–5) | 4.17±0.74 | 4.26±0.57 | −0.43 (0.671) |
| Not at all (1) | 1 (1.4) | 0 (0) | |
| Not likely (2) | 0 (0) | 0 (0) | |
| Don’t know (3) | 8 (11.4) | 3 (6.5) | |
| Fairly likely (4) | 38 (54.3) | 28 (60.9) | |
| Very likely (5) | 23 (32.9) | 15 (32.6) | |
| HPV knowledge |
|
| |
| High-risk HPV causes STDs (F) | 12 (17.1) | 15 (32.6) | 3.72 (0.156) |
| Low-risk HPV causes genital cancer (F) | 33 (47.8) | 19 (42.2) | 0.52 (0.770) |
| Genital warts always cause pain (F) | 30 (42.9) | 23 (50.0) | 0.62 (0.735) |
| Genital warts cause cervical cancer (F) | 20 (28.6) | 14 (31.1) | 0.20 (0.904) |
| Cervical cancer is preventable (T) | 55 (79.7) | 38 (84.4) | 0.41 (0.816) |
| Genital warts are preventable (T) | 57 (81.4) | 37 (84.1) | 1.63 (0.444) |
| HPV vaccine prevents STD (T) | 55 (79.7) | 39 (86.7) | 0.93 (0.629) |
| HPV vaccine prevents cervical cancer (T) | 53 (75.7) | 38 (84.4) | 2.04 (0.360) |
| HPV knowledge score (0–8) | 4.58±2.26 | 4.95±1.89 | 0.80 (0.373) |
| Cronbach’s α for eight items=0.85 | |||
*Mann–Whitney U test.
F, false; T, true.
Gender comparisons of correlations among health-belief variables, HPV knowledge, and intention to obtain the HPV vaccination at posttest
|
|
| |
|---|---|---|
|
|
| |
|
| ||
| Health-belief variables at posttest | ||
| Severity of STDs | 0.38 (0.001) | 0.49 (0.001) |
| Severity of cancer | 0.30 (0.013) | 0.36 (0.015) |
| Intention to obtain injection for STD prevention | 0.85 (<0.001) | 0.85 (0.001) |
| Intention to obtain injection for cancer prevention | 0.21 (<0.001) | 0.79 (<0.001) |
| Concern about pain at vaccine injectiona | 0.18 (0.131) | 0.40 (0.006) |
| Benefit of STD prevention injection | 0.60 (<0.001) | 0.43 (0.003) |
| Benefit of cancer prevention injection | 0.64 (<0.001) | 0.53 (<0.001) |
| HPV knowledgeb | ||
| High-risk HPV causes STD | 0.03 (0.796) | 0.07 (0.639) |
| Low-risk HPV causes genital cancer | 0.19 (0.128) | 0.00 (0.989) |
| Genital warts always cause pain | 0.21 (0.078) | 0.15 (0.312) |
| Genital warts cause cervical cancer | 0.04 (0.774) | 0.18 (0.238) |
| Cervical cancer is preventable | 0.12 (0.319) | 0.16 (0.282) |
| Genital warts are preventable | 0.23 (0.054) | −0.03 (0.856) |
| HPV vaccine prevents STDs | 0.23 (0.060) | 0.18 (0.251) |
| HPV vaccine prevents cervical cancer | 0.25 (0.039) | 0.31 (0.037) |
aReverse coding; bdummy variables (0, incorrect answer or don’t know; 1, corrected answer).
STD, sexually transmitted disease; HPV, human papillomavirus.